| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P2093 | author name string | M J Alberts | |
| M O McCarron | |||
| D Delong | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | APOE e4 | Q96781931 |
| meta-analysis | Q815382 | ||
| risk factor | Q1475848 | ||
| cerebrovascular disease | Q3010352 | ||
| P304 | page(s) | 1308-11 | |
| P577 | publication date | 1999-10-12 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis | |
| P478 | volume | 53 |
| Q35840292 | A genome-wide scan for common variants affecting the rate of age-related cognitive decline |
| Q35778546 | APOE Polymorphism Is Associated with C-reactive Protein Levels but Not with White Blood Cell Count: Dong-gu Study and Namwon Study |
| Q48208048 | APOE does not predict poor outcome 1 year after ischemic stroke |
| Q37360798 | APOE genotype modifies the relationship between midlife vascular risk factors and later cognitive decline |
| Q36974143 | APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study |
| Q34284883 | Advances in molecular genetics and pathology of cerebrovascular disorders |
| Q37281552 | Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study |
| Q38877586 | Alzheimer disease genetic risk factor APOE e4 and cognitive abilities in 111,739 UK Biobank participants |
| Q47367180 | Alzheimer's disease: role of size and location of white matter changes in determining cognitive deficits. |
| Q33672569 | Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease |
| Q64068852 | ApoE4: an emerging therapeutic target for Alzheimer's disease |
| Q36546467 | Apolipoprotein (apo) E4 and Alzheimer's disease: unique conformational and biophysical properties of apoE4 can modulate neuropathology |
| Q37601104 | Apolipoprotein E (Apo E) gene polymorphisms and recurrent pregnancy loss: a meta-analysis |
| Q34013483 | Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly |
| Q48218025 | Apolipoprotein E and first-ever ischaemic stroke in Greek hospitalized patients |
| Q36932008 | Apolipoprotein E epsilon4 allele and outcomes of traumatic spinal cord injury. |
| Q30360209 | Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study |
| Q48397851 | Apolipoprotein E epsilon4 allele is associated with the volume of white matter changes in patients with lacunar infarcts |
| Q37995441 | Apolipoprotein E gene polymorphism in a Chinese population with vascular dementia: a meta-analysis |
| Q77384926 | Apolipoprotein E gene polymorphisms in patients with migraine |
| Q45054674 | Apolipoprotein E genotype and lifetime cognitive decline. |
| Q94334053 | Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery |
| Q48187762 | Apolipoprotein E genotype and subcortical vascular lesions in older depressed patients and control subjects |
| Q51905657 | Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia. |
| Q46535385 | Apolipoprotein E genotyping and questionnaire-based assessment of lifestyle risk factors in dyslipidemic patients with a family history of Alzheimer's disease: test development for clinical application. |
| Q35068761 | Apolipoprotein E polymorphism and atherosclerosis |
| Q40762156 | Apolipoprotein E polymorphism and functional disability in Brazilian elders: the Bambuí Health and Aging Study |
| Q43734715 | Apolipoprotein E polymorphism and lipid levels differ by gender and family history of diabetes: the Rancho Bernardo Study |
| Q54701449 | Apolipoprotein E polymorphism and stroke in a population from eastern Turkey. |
| Q44300579 | Apolipoprotein E polymorphism and stroke subtypes in an Italian cohort. |
| Q47877239 | Apolipoprotein E polymorphism in patients with neuropsychiatric SLE. |
| Q51165338 | Apolipoprotein E polymorphisms and ischaemic stroke: a two-center Greek study. |
| Q47429290 | Apolipoprotein E ɛ4, Cognitive Function, and Pain Experience in Down Syndrome: A Pilot Study |
| Q22248091 | Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease |
| Q34621541 | Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases |
| Q36963238 | Apolipoprotein e sets the stage: response to injury triggers neuropathology |
| Q33935221 | Apolipoprotein e4 genotype and depressive symptoms as risk factors for dementia in an older korean population |
| Q34688023 | Apolipoproteins and aging: emerging mechanisms |
| Q37306445 | Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years |
| Q48244141 | Association between apolipoprotein E4 and rehabilitation outcome in hospitalized ischemic stroke patients. |
| Q30588614 | Association between the apolipoprotein E gene polymorphism and ischemic stroke in Chinese populations: New data and meta-analysis |
| Q49487950 | Association of apolipoprotein E genotype with outcome in hospitalized ischemic stroke patients |
| Q46733684 | Association of refractory complex partial seizures with a polymorphism of ApoE genotype. |
| Q36249248 | Atherosclerotic and thrombotic genetic and environmental determinants in Egyptian coronary artery disease patients: a pilot study. |
| Q47385360 | Augmented delayed infarct expansion and reactive astrocytosis after permanent focal ischemia in apolipoprotein E4 knock-in mice |
| Q36906438 | BDNF Genotype Interacts with Motor Function to Influence Rehabilitation Responsiveness Poststroke |
| Q38986047 | Candidate genes and risk for CP: a population-based study |
| Q40559401 | Caution in the use of the apolipoprotein E e4 allele as a predictor of healthcare costs |
| Q35486023 | Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype |
| Q26771852 | Cerebrovascular disease in ageing and Alzheimer's disease |
| Q99207518 | Cerebrovascular risk factors impact frontoparietal network integrity and executive function in healthy ageing |
| Q53802856 | Common variants of APOE are associated with anti-epileptic drugs resistance in Han Chinese patients. |
| Q43948390 | DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic |
| Q54543631 | Difference in apolipoprotein E type 4 allele (APOE epsilon 4) among dentate and edentulous subjects. |
| Q35135403 | Do long-term HDL-C declines associated with a first birth vary by apo E phenotype? The Coronary Artery Risk Development in Young Adults (CARDIA) study |
| Q36356533 | Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. |
| Q37768794 | Genetic aspects of ischemic stroke: coagulation, homocysteine, and lipoprotein metabolism as potential risk factors |
| Q36054834 | Genetic association of APOA5 and APOE with metabolic syndrome and their interaction with health-related behavior in Korean men |
| Q37672948 | Genetic determinants of cerebral vasospasm, delayed cerebral ischemia, and outcome after aneurysmal subarachnoid hemorrhage |
| Q37141815 | Genetic polymorphisms for the study of multifactorial stroke. |
| Q36515111 | Genetic risk factors for perinatal arterial ischemic stroke |
| Q35708128 | Genetic risk factors for stroke and carotid atherosclerosis: insights into pathophysiology from candidate gene approaches |
| Q35008517 | Genetics of ischemic stroke. |
| Q37206266 | Genetics of stroke: a review of recent advances. |
| Q45106065 | High apolipoprotein E4 allele frequency in FXTAS patients. |
| Q34352230 | Homocysteine, Another Risk Factor for Alzheimer Disease, Impairs Apolipoprotein E3 Function |
| Q30502206 | IQ, educational attainment, memory and plasma lipids: associations with apolipoprotein E genotype in 5995 children |
| Q48363901 | Increased vulnerability to focal ischemic brain injury in human apolipoprotein E4 knock-in mice |
| Q44417626 | Influence of the polymorphism of apolipoprotein E in cerebral vascular disease |
| Q44583853 | LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease |
| Q59192497 | LPL polymorphism predicts stroke risk in men |
| Q48805335 | Lack of association between apolipoprotein E genoype and ischaemic stroke in a Scottish population. |
| Q37985837 | Large-scale meta-analysis of genetic studies in ischemic stroke: Five genes involving 152,797 individuals |
| Q34412109 | Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status |
| Q64106674 | Low Evolutionary Selection Pressure in Senescence Does Not Explain the Persistence of Aβ in the Vertebrate Genome |
| Q48866034 | MRI and genetic correlates of cognitive function in elders with memory impairment |
| Q38763038 | Management of acute ischaemic stroke in patients with dementia |
| Q96230266 | Melatonin-induced ApoE expression in mouse astrocytes protects endothelial cells from OGD-R induced injuries |
| Q53117762 | Meta-analysis of APOE ε2/ε3/ε4 polymorphism and cerebral infarction. |
| Q53243706 | Modulation by age and gender of risk for Alzheimer's disease and vascular dementia associated with the apolipoprotein E-epsilon4 allele in Latin Americans: findings from the Maracaibo Aging Study. |
| Q45250144 | Modulation of astrocytic activation by arundic acid (ONO-2506) mitigates detrimental effects of the apolipoprotein E4 isoform after permanent focal ischemia in apolipoprotein E knock-in mice |
| Q36723293 | Neurodevelopmental outcomes following congenital heart surgery |
| Q34953672 | Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene. |
| Q92663401 | Pathogenesis of Ischemic Stroke: Role of Epigenetic Mechanisms |
| Q37199221 | Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders |
| Q42193827 | Physiologic Reelin does not play a strong role in protection against acute stroke. |
| Q44765109 | Plasma levels of apolipoprotein E and risk of intracranial artery stenosis in acute ischemic stroke patients |
| Q36172468 | Poststroke dementia in the elderly. |
| Q44947299 | Relation of apolipoprotein(a) size to alzheimer's disease and vascular dementia. |
| Q36533093 | Research actuality in the genetics of stroke |
| Q44230227 | Risk factors for cryptogenic ischaemic stroke |
| Q45248050 | Role of apolipoprotein E epsilon 4 allele on chronic allograft nephropathy after renal transplantation. |
| Q26799413 | Role of apolipoprotein E in neurodegenerative diseases |
| Q34055011 | Role of vascular risk factors and vascular dysfunction in Alzheimer's disease |
| Q36522909 | Single gene disorders causing ischaemic stroke |
| Q34768687 | Single nucleotide polymorphisms of thrifty genes for energy metabolism: evolutionary origins and prospects for intervention to prevent obesity-related diseases |
| Q30421643 | Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology |
| Q99708499 | Spatial distribution and cognitive impact of cerebrovascular risk-related white matter hyperintensities |
| Q34271990 | Stroke and cognition. |
| Q50790461 | Synergistic associations of depression and apolipoprotein E genotype with incidence of dementia. |
| Q53322019 | The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes. |
| Q40484018 | The Apolipoprotein E Epsilon (epsilon) 4 Allele Is Important for Trauma-related Epilepsy |
| Q35844835 | The Association Between Apolipoprotein E and Functional Outcome After Traumatic Brain Injury: A Meta-Analysis |
| Q44247540 | The apolipoprotein E epsilon4 haplotype is an important predictor for recurrence in ischemic cerebrovascular disease |
| Q48233581 | The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities |
| Q64962426 | The association between apolipoprotein E and gallstone disease: an updated meta-analysis. |
| Q37364340 | The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology |
| Q41946920 | The effect of ApoE e4 on blood pressure in patients with and without depression |
| Q37399974 | The genomic basis of cerebral palsy: a HuGE systematic literature review |
| Q33950398 | The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models |
| Q73674062 | The role of apolipoprotein E in cognitive decline after cardiac operation |
| Q38206263 | The role of apolipoprotein E in neurodegeneration and cardiovascular disease |
| Q30772211 | There is no evidence of an association in children and teenagers between the apolipoprotein E epsilon4 allele and post-traumatic brain swelling |
| Q40006176 | Traumatic brain injury: future assessment tools and treatment prospects |
| Q51889308 | White matter lesion load increases the risk of low CSF Aβ42 in apolipoprotein E-ɛ4 carriers attending a memory clinic. |
Search more.